Search Results 491-500 of 17321 for Proto-oncogene

  1. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  2. Epigenetic Etiology of Human Disease: Keith D. Robertson

    Mayo Clinic's Epigenetic Etiology of Human Disease Lab, led by Keith D. Robertson, Ph.D., studies DNA methylation and hydroxymethylation in health and ...

  3. Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL) - Mayo Clinic

    Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With ...

  4. https://www.mayoclinic.org/patient_consumer_faq.xml

  5. Detection of Esophageal Cancer by Assay of Novel Methylated DNA Markers in Plasma - Mayo Clinic

    The purpose of the study is to see if the plasma assay of MDMs using optimized markers and analytically sensitive assays will detect early-stage esophageal ...

  6. Head and neck cancers - Doctors and departments - Mayo Clinic

    Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.

  7. Hodgkin Lymphoma (Hodgkin Disease) Clinical Trials - Mayo Clinic Research

    Everolimus may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Brentuximab vedotin may interfere with the ability of ...

  8. Germ cell tumors - Doctors and departments - Mayo Clinic

    Learn about these tumors that form from reproductive cells. Explore treatment options, including surgery, chemotherapy and radiation therapy.

  9. Early-Onset and Hereditary GI Cancers Program - Conditions treated - Mayo Clinic

    They also are specialized to care for patients with or without cancer who have an inherited or genetic predisposition to cancer. This care coordinates genetic ...

  10. Obinutuzumab With or Without PI3K-delta Inhibitor TGR-1202, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma - Mayo Clinic

    PI3K-delta inhibitor TGR-1202 may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Biological therapies, such as ...